Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E9EE
|
|||
Former ID |
DCL000232
|
|||
Drug Name |
SR 144190
|
|||
Synonyms |
SR-144190; 3-(1-(2-(4-benzoyl-2-(3,4-difluorophenyl)morpholin-2-yl)ethyl)-4-phenylpiperidin-4-yl)-1-dimethylurea
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Acute or chronic pain [ICD-11: MG30-MG31] | Discontinued in Phase 1 | [1] | |
Anxiety disorder [ICD-11: 6B00-6B0Z] | Discontinued in Phase 1 | [1] | ||
Depression [ICD-11: 6A70-6A7Z] | Discontinued in Phase 1 | [1] | ||
Urinary incontinence [ICD-11: MF50.2] | Discontinued in Phase 1 | [1] | ||
Therapeutic Class |
Analgesics
|
|||
Company |
Sanofi-aventis
|
|||
Structure |
Download2D MOL |
|||
Formula |
C33H38F2N4O3
|
|||
Canonical SMILES |
CN(C)C(=O)NC1(CCN(CC1)CCC2(CN(CCO2)C(=O)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5
|
|||
InChI |
1S/C33H38F2N4O3/c1-37(2)31(41)36-32(26-11-7-4-8-12-26)15-18-38(19-16-32)20-17-33(27-13-14-28(34)29(35)23-27)24-39(21-22-42-33)30(40)25-9-5-3-6-10-25/h3-14,23H,15-22,24H2,1-2H3,(H,36,41)
|
|||
InChIKey |
QNLIUVLFRVYNCV-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Substance-K receptor (TACR2) | Target Info | Antagonist | [2], [3] |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Reactome | G alpha (q) signalling events | |||
WikiPathways | Gastrin-CREB signalling pathway via PKC and MAPK | |||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008589) | |||
REF 2 | Pharmacologic evaluation of neurokinin-2 receptor antagonists in the guinea pig respiratory tract. Am J Vet Res. 2004 Jul;65(7):984-91. | |||
REF 3 | Antagonists at the neurokinin receptors--recent patent literature. IDrugs. 2003 Aug;6(8):758-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.